Pfizer Inc
Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition
Bristol Myers Squibb on Thursday reported quarterly adjusted earnings that topped expectations and posted revenue in line with estimates, even as sales of the company’s popular blood cancer drug Revlimid plummeted due to generic competition. Bristol Myers, one of the world’s largest pharmaceutical companies, raked in $10.96 billion in revenue for the third quarter, down […]
Read More
Merck results beat expectations on strong Keytruda sales, surprise Covid drug growth
Merck headquarters in Rahway, New Jersey, on Tuesday, April 18, 2023. Christopher Occhicone | Bloomberg | Getty Images Merck on Thursday reported third-quarter revenue and adjusted earnings that topped expectations on strong sales of its blockbuster cancer drug Keytruda, HPV vaccine Gardasil and surprisingly, its Covid drug Lagevrio. The pharmaceutical giant also increased its full-year […]
Read More
RSV vaccine from GSK shows potential to protect adults 50 to 59
A vaccine from GlaxoSmithKline showed the potential to protect adults ages 50 to 59 from respiratory syncytial virus in a late-stage clinical trial, the company said Wednesday. The initial trial results suggest that GSK’s shot, known as Arexvy, could help protect a wider population from RSV, a disease that causes thousands of hospitalizations and deaths […]
Read More
Pfizer to price Covid drug Paxlovid at $1,390 per course
Paxlovid, Pfizer’s antiviral medication to treat the coronavirus disease, is displayed in this picture taken on Oct. 7, 2022. Wolfgang Rattay | Reuters Pfizer will price a five-day course of its Covid antiviral drug Paxlovid at $1,390 when the company starts to transition it to the commercial market later this year. A company spokesperson on […]
Read More
Stocks creating the greatest moves midday: Lululemon, Pfizer, News Corp, Charles Schwab and extra
Examine out the businesses producing the greatest moves midday. Lululemon — Shares of the athleisure apparel business surged much more than 10% right after S & P Dow Jones Indices declared that the firm’s stock will be included to the S & P 500 on Wednesday. Lululemon will replace Activision Blizzard following the completion of […]
Read More
Pfizer gets upgrade at Jefferies, which says there’s a buying opportunity in the pharma giant’s stock
Jefferies thinks it’s time for investors to go long on Pfizer . The firm upgraded the pharmaceutical stock to buy from hold in a Monday note and increased its price target to $39 per share from $38. Jefferies’ forecast calls for roughly 21% upside from Friday’s $32.11 close. Analyst Akash Tewari said that while the […]
Read More
Pfizer slashes full-year earnings and revenue guidance as Covid treatment, vaccine sales slump
Pfizer CEO Albert Bourla talks during a press conference with the president of the European Commission after a visit to oversee the production of the Pfizer-BioNTech Covid-19 vaccine at the factory of U.S. pharmaceutical company Pfizer, in Puurs, Belgium, April 23, 2021. John Thys | AFP | Getty Images Pfizer slashed its full-year earnings and […]
Read More
New RSV protections for infants hit cost, insurance hurdles in U.S. rollout
A doctor vaccinates an infant against respiratory syncytial virus (RSV) in a treatment room of her paediatric practice. Swen Pförtner | Picture Alliance | Getty Images Two new immunizations promise to protect babies from respiratory syncytial virus – if people can find them. Providers are scrambling to offer Pfizer’s vaccine, Abrysvo, to pregnant patients and […]
Read More
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
Danish drugmaker Novo Nordisk has entered a new chapter in its 100-year history — thanks to its newfound success with two products: Ozempic and Wegovy. The drugs are once-weekly injectables of a medication called semaglutide, prescribed for Type 2 diabetes and weight loss. Their skyrocketing popularity has boosted Novo Nordisk to new heights. Novo Nordisk’s […]
Read More
Novavax’s updated Covid vaccine can still catch up to Pfizer, Moderna shots this fall
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Americans can finally get their hands on Novavax‘s newest Covid vaccine after U.S. regulators greenlighted the shot this week. […]
Read More